Decision tree analysis identified three distinct subgroups of RUNX1-RUNX1T1 AML on the basis of reduction in the level of RUNX1-RUNX1T1 transcript and mutation profile (Fig. 5a). This evidence concerns the gene RUNX1 and acute myeloid leukemia.